Harper SJ - Search Results

1

VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy.

Varey AH, Rennel ES, Qiu Y, Bevan HS, Perrin RM, Raffy S, Dixon AR, Paraskeva C, Zaccheo O, Hassan AB, Harper SJ, Bates DO. Varey AH, et al. Among authors: harper sj. Br J Cancer. 2008 Apr 22;98(8):1366-79. doi: 10.1038/sj.bjc.6604308. Epub 2008 Mar 18. Br J Cancer. 2008. PMID: 18349829 Free PMC article.

2

A single human colonic adenoma cell line can be converted in vitro to both a colorectal adenocarcinoma and a mucinous carcinoma.

Paraskeva C, Hague A, Rooney N, Williams AC, Harper SJ, Hanlon KA, Atkinson RJ, Corfield AP. Paraskeva C, et al. Among authors: harper sj. Int J Cancer. 1992 Jun 19;51(4):661-4. doi: 10.1002/ijc.2910510426. Int J Cancer. 1992. PMID: 1318272

3

Specific cytogenetic abnormalities and k-ras mutation in two new human colorectal-adenoma-derived cell lines.

Williams AC, Harper SJ, Marshall CJ, Gill RW, Mountford RA, Paraskeva C. Williams AC, et al. Among authors: harper sj. Int J Cancer. 1992 Nov 11;52(5):785-90. doi: 10.1002/ijc.2910520519. Int J Cancer. 1992. PMID: 1428233

4

Neoplastic transformation of a human colonic epithelial cell line: in vitro evidence for the adenoma to carcinoma sequence.

Williams AC, Harper SJ, Paraskeva C. Williams AC, et al. Among authors: harper sj. Cancer Res. 1990 Aug 1;50(15):4724-30. Cancer Res. 1990. PMID: 2369746

5

Human uremic plasma increases microvascular permeability to water and proteins in vivo.

Harper SJ, Tomson CR, Bates DO. Harper SJ, et al. Kidney Int. 2002 Apr;61(4):1416-22. doi: 10.1046/j.1523-1755.2002.00252.x. Kidney Int. 2002. PMID: 11918748 Free article.

6

VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma.

Bates DO, Cui TG, Doughty JM, Winkler M, Sugiono M, Shields JD, Peat D, Gillatt D, Harper SJ. Bates DO, et al. Among authors: harper sj. Cancer Res. 2002 Jul 15;62(14):4123-31. Cancer Res. 2002. PMID: 12124351

7

ZM323881, a novel inhibitor of vascular endothelial growth factor-receptor-2 tyrosine kinase activity.

Whittles CE, Pocock TM, Wedge SR, Kendrew J, Hennequin LF, Harper SJ, Bates DO. Whittles CE, et al. Among authors: harper sj. Microcirculation. 2002 Dec;9(6):513-22. doi: 10.1038/sj.mn.7800164. Microcirculation. 2002. PMID: 12483548

8

Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes.

Foster RR, Hole R, Anderson K, Satchell SC, Coward RJ, Mathieson PW, Gillatt DA, Saleem MA, Bates DO, Harper SJ. Foster RR, et al. Among authors: harper sj. Am J Physiol Renal Physiol. 2003 Jun;284(6):F1263-73. doi: 10.1152/ajprenal.00276.2002. Epub 2003 Mar 4. Am J Physiol Renal Physiol. 2003. PMID: 12620928 Free article.

9

Endothelial permeability in uremia.

Harper SJ, Bates DO. Harper SJ, et al. Kidney Int Suppl. 2003 May;(84):S41-4. doi: 10.1046/j.1523-1755.63.s84.15.x. Kidney Int Suppl. 2003. PMID: 12694306 Free article. Review.

10

Regulation of vascular permeability by vascular endothelial growth factors.

Bates DO, Harper SJ. Bates DO, et al. Among authors: harper sj. Vascul Pharmacol. 2002 Nov;39(4-5):225-37. doi: 10.1016/s1537-1891(03)00011-9. Vascul Pharmacol. 2002. PMID: 12747962 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

231 results

Search Page